Chandler and Grant's Glaucoma
SLACK Incorporated (Verlag)
978-1-55642-954-5 (ISBN)
Meticulous updating from the previous edition maintains the well-established historical teachings of Drs Paul A. Chandler and Morton W. Grant and defines this new fifth edition as the most relevant and invaluable reference on the topic of glaucoma.
Exploring subject areas from the mechanisms behind clinical observation to the details on treating the individual patient in the office, it brings together the experience of world-class glaucoma experts trained from the original teachings of this book.
New topics and features in the Fifth Edition:
Advances in imaging of the optic nerve and retina
Updates on medical therapy of glaucoma
New approaches for minimally invasive glaucoma surgery
Over 400 images and tables
Malik Y. Kahook, MD is Professor of Ophthalmology and Director of Clinical and Translational Research in the Department of Ophthalmology at the University of Colorado. He also directs the glaucoma service and glaucoma fellowship. Dr. Kahook specializes in the medical and surgical treatment of glaucoma and cataracts. He is active within the ophthalmology community, including memberships in the American Academy of Ophthalmology, American Glaucoma Society, American Society of Refractive and Cataract Surgeons, and the Association for Research in Vision and Ophthalmology. Dr. Kahook has authored more than 200 peer-reviewed manuscripts, abstracts, and book chapters, and is editor of 4 textbooks, including Essentials of Glaucoma Surgery (SLACK Incorporated). He is on the editorial board of the American Journal of Ophthalmology and International Glaucoma Review, among others. He was awarded an American Glaucoma Society Clinician-Scientist Fellowship Award for 2007, as well as the American Glaucoma Society Compliance Grant for 2006, and was named New Inventor of the Year for the University of Colorado in 2009 and Inventor of the Year for 2010. Dr. Kahook received the American Academy of Ophthalmology Achievement Award in 2011. He has filed for more than 12 patents, several of which have been licensed by companies for development and commercialization. He currently serves as a consultant to the US Food and Drug Administration’s Ophthalmic Device Division. Dr. Kahook completed his residency training at the University of Colorado, Rocky Mountain Lions Eye Institute in Denver, Colorado, where he was named Chief Resident. He then went on to complete his fellowship in glaucoma from the University of Pittsburgh Medical Center in Pittsburgh, Pennsylvania. Joel S. Schuman, MD, FACS is the Eye and Ear Foundation Professor and Chairman of Ophthalmology, the Eye and Ear Institute, University of Pittsburgh School of Medicine and Director of the University of Pittsburgh Medical Center (UPMC) Eye Center. He is also Professor of Bioengineering at the Swanson School of Engineering, University of Pittsburgh, and a Founder of the Louis J. Fox Center for Vision Restoration of UPMC and the University of Pittsburgh. He is a member of the McGowan Institute for Regenerative Medicine and the Center for the Neural Basis of Cognition, Carnegie Mellon University and University of Pittsburgh. Dr. Schuman is a native of Roslyn, New York; he graduated from Columbia University (BA, 1980) and Mt. Sinai School of Medicine (MD, 1984). Following his internship at New York’s Beth Israel Medical Center (1985), he completed residency training at Medical College of Virginia (1988) and glaucoma fellowship at Massachusetts Eye & Ear Infirmary (clinical 1989; research 1990), where he was a Heed Fellow. After just over a year on the Harvard faculty, he moved to the New England Medical Center, Tufts University, to co-found the New England Eye Center in 1991, where he was Residency Director and Glaucoma and Cataract Service Chief. In 1998, he became Professor of Ophthalmology, and Vice Chair in 2001. Dr. Schuman and his colleagues were the first to identify a molecular marker for human glaucoma, as published in Nature Medicine in 2001. He has been continuously funded by the National Eye Institute as a principal investigator since 1995, is principal investigator of a National Institutes of Health (NIH) grant to study novel glaucoma diagnostics, and is co-investigator of NIH grants for research into novel optical diagnostics and short pulse laser surgery and for advanced imaging in glaucoma. He is an inventor of optical coherence tomography (OCT), used world-wide for ocular diagnostics. Dr. Schuman has published more than 250 peer-reviewed scientific journal articles, has authored or edited 8 books, and has contributed more than 50 book chapters. In 2002, Dr. Schuman received the Alcon Research Institute Award, as well as the New York Academy of Medicine’s Lewis Rudin Glaucoma Prize. In 2003, he received the Senior Achievement Award from the American Academy of Ophthalmology. In 2004, he was elected into the American Society for Clinical Investigation. In 2006, he received the Association for Research in Vision and Ophthalmology (ARVO) Translational Research Award. He was elected to the American Ophthalmological Society in 2008. He received a 2006-2009 American Medical Association Physician’s Recognition Award with Commendation. In 2010, he became a silver Fellow of ARVO. In 2011, Dr. Schuman was the Clinician-Scientist Lecturer of the American Glaucoma Society. In 2012, he received the Carnegie Science Center’s Award in Life Sciences and was a co-recipient of the Champalimaud Award.
Dedication
Acknowledgments
About the Editors
Contributing Authors
Preface
Introduction
Section I The Basics
Chapter 1 Introduction Joel S. Schuman, MD, FACS and David L. Epstein, MD, MMM
Chapter 2 Anatomy Malik Y. Kahook, MD and E. Michael Van Buskirk, M D
Peripapillary Atrophy: Joel S. Schuman, MD, FACS and Malik Y. Kahook, MD
Chapter 3 Practical Aqueous Humor Dynamics Joel S. Schuman, MD, FACS; Malik Y. Kahook, MD; and David L. Epstein, MD, MMM
An Interesting Question: David L. Epstein, MD, MMM
Testing of New Glaucoma Drugs: David L. Epstein, MD, MMM
Chapter 4 The Patient’s History: Symptoms of Glaucoma Joel S. Schuman, MD, FACS and David L. Epstein, MD, MMM
Steroid-Induced Elevation of Intraocular Pressure: David L. Epstein, MD, MMM
Chapter 5 Examination of the Eye Ian P. Conner, MD, PhD; Joel S. Schuman, MD, FACS; Malik Y. Kahook, MD; and David L. Epstein, MD, MMM
The Rule of 5%: David L. Epstein, MD, MMM
Chapter 6 Tonometry and Tonography Jeremy B. Wingard, MD and Joel S. Schuman, MD, FACS
Chapter 7 The Angle of the Anterior Chamber Joel S. Schuman, MD, FACS; Deval Joshi, MD; and Lisa S. Gamell, MD
Gonioscopy During Operation: Joel S. Schuman, MD, FACS
Chapter 8 Examination of the Optic Nerve Ian P. Conner, MD, PhD; Joel S. Schuman, MD, FACS; and David L. Epstein, MD, MMM
Clinical Assessment of the Nerve Fiber Layer: Joel S. Schuman, MD, FACS
Chapter 9 Imaging of the Optic Nerve Head and Nerve Fiber Layer Lindsey S. Folio, MS, MBA; Gadi Wollstein, MD; and Joel S. Schuman, MD, FACS
Chapter 10 Imaging Devices for Angle Assessment Mina B. Pantcheva, MD and Malik Y. Kahook, MD
Chapter 11 Visual Fields and Their Relationship to the Optic Nerve Joshua D. Stein, MD, MS and R. Rand Allingham, MD
Section II Medications Used in Glaucoma Therapy
Chapter 12 Adrenergic Agents: Blockers and Agonists Pratap Challa, MD, MS and David L. Epstein, MD, MMM
Evaluating Clinical Trials: Pratap Challa, MD, MS and David L. Epstein, MD, MMM
Timolol and Albino Rabbits: Pratap Challa, MD, MS and David L. Epstein, MD, MMM
Laboratory Glaucoma Models: Pratap Challa, MD, MS and David L. Epstein, MD, MMM
Statistical and Clinical Significance: Pratap Challa, MD, MS and David L. Epstein, MD, MMM
Mechanisms of Epinephrine-Induced Cystoid Macular Edema: Pratap Challa, MD, MS and
David L. Epstein, MD, MMM
Chapter 13 The Miotics Pratap Challa, MD, MS and David L. Epstein, MD, MMM
Acetylcholinesterase: David L. Epstein, MD, MMM
Drug Therapy Compliance: David L. Epstein, MD, MMM
Limited Duration of Activity of Phospholine Iodide: David L. Epstein, MD, MMM
Chapter 14 Carbonic Anhydrase Inhibitors: Systemic Use Pratap Challa, MD, MS and David L. Epstein, MD, MMM
Chapter 15 Topical Carbonic Anhydrase Inhibitors Pratap Challa, MD, MS and Joel S. Schuman, MD, FACS
Chapter 16 Prostaglandin Analogs Angela V. Turalba, MD and Douglas J. Rhee, MD
Chapter 17 Management of Highly Elevated Intraocular Pressure Joshua D. Stein, MD, MS; R. Rand Allingham, MD; and Pratap Challa, MD, MS
Section III Common Open-Angle Glaucomas
Chapter 18 Primary Open-Angle Glaucoma Kimberly V. Miller, MD; Joel S. Schuman, MD, FACS; and David L. Epstein, MD, MMM
Primary Open-Angle Glaucoma and Myopia: David L. Epstein, MD, MMM
Common Mistakes in Glaucoma Management: David L. Epstein, MD, MMM
Trabecular Glaucoma Versus Optic Nerve Glaucoma: David L. Epstein, MD, MMM
Tonography: David L. Epstein, MD, MMM
Chapter 19 Low-Tension Glaucoma Ian P. Conner, MD, PhD; Kimberly V. Miller, MD; Joel S. Schuman, MD, FACS; and David L. Epstein, MD, MMM
Low-Tension Glaucoma and the General Ophthalmologist: David L. Epstein, MD, MMM
Ocular Effects of Calcium-Channel Blockers: Past Promise: Peter A. Netland, MD, PhD
Chapter 20 Pseudoexfoliation Syndrome and Open-Angle Glaucoma Pratap Challa, MD, MS and David L. Epstein, MD, MMM
Tonography in Pseudoexfoliation: Pratap Challa, MD, MS and David L. Epstein, MD, MMM
Chapter 21 Pigment Dispersion and Pigmentary Glaucoma Ian P. Conner, MD, PhD; Kimberly V. Miller, MD; Joel S. Schuman, MD, FACS; and David L. Epstein, MD, MMM
Tonography: David L. Epstein, MD, MMM
Section IV Angle-Closure Glaucoma
Chapter 22 Principles of Primary Angle-Closure Glaucoma George Ulrich, MD, FACS and David L. Epstein, MD, MMM
Iris Retraction Syndrome: David L. Epstein, MD, MMM
Pseudo-Unilateral Angle Closure: David L. Epstein, MD, MMM
Chapter 23 Acute Angle-Closure Glaucoma: Diagnosis and Treatment George Ulrich, MD, FACS; Joel S. Schuman, MD, FACS; David L. Epstein, MD, MMM; and Ian P. Conner, MD, PhD
Anterior Chamber Deepening With Mechanical Breaking of Peripheral Anterior Synechiae With an
Iris Spatula (Goniosynechialysis): David L. Epstein, MD, MMM
Chapter 24 Subacute (and Chronic) Angle-Closure Glaucoma George Ulrich, MD, FACS and David L. Epstein, MD, MMM
Chapter 25 Angle-Closure Glaucoma: Evaluation and Treatment After Iridotomy Mina B. Pantcheva, MD; Malik Y. Kahook, MD; and David L. Epstein, MD, MMM
Chapter 26 Plateau Iris Joel S. Schuman, MD, FACS; Malik Y. Kahook, MD; and David L. Epstein, MD, MMM
Chapter 27 The Use of Special Tests in Narrow-Angled Eyes Joel S. Schuman, MD, FACS and David L. Epstein, MD, MMM
Goniolens Characteristics: R. Rand Allingham, MD
Section V Secondary Angle-Closure Glaucomas
Chapter 28 Principles of Secondary Angle-Closure Glaucomas David L. Epstein, MD, MMM
Chapter 29 The Malignant Glaucoma Syndromes Ian P. Conner, MD, PhD; Joel S. Schuman, MD, FACS; and David L. Epstein, MD, MMM
The History of Mydriatic-Cycloplegic Therapy: David L. Epstein, MD, MMM
The Chandler Operation: Ian P. Conner, MD, PhD; Joel S. Schuman, MD, FACS; and
David L. Epstein, MD, MMM
Chapter 30 Nanophthalmos: Diagnosis and Treatment Zvia Burgansky-Eliash, MD and Richard J. Simmons, MD
Chapter 31 Neovascular Glaucoma Jeffrey R. SooHoo, MD; David K. Dueker, MD; and Malik Y. Kahook, MD
Chapter 32 Iridocorneal Endothelial Syndromes Sarwat Salim, MD, FACS and M. Bruce Shields, MD
Chapter 33 Glaucoma After Vitreoretinal Procedures Ron A. Adelman, MD, MPH, MBA, FACS and Martin Wand, MD
Intraocular Gas and Altitude: Martin Wand, MD and Ron A. Adelman, MD, MPH, MBA, FACS
Chapter 34 Angle-Closure Glaucoma Due to Multiple Cysts of the Iris and Ciliary Body Ian P. Conner, MD, PhD; Joel S. Schuman, MD, FACS; and David L. Epstein, MD, MMM
Chapter 35 Angle-Closure Glaucoma Secondary to Occlusion of the Central Retinal Vein Malik Y. Kahook, MD and David L. Epstein, MD, MMM
Chapter 36 Angle-Closure Glaucoma Secondary to Acute Myopia Malik Y. Kahook, MD and David L. Epstein, MD, MMM
Acute Bilateral Transitory Myopia Associated With Open-Angle Glaucoma: Joel S. Schuman, MD, FACS
Chapter 37 Glaucoma After Penetrating Keratoplasty Mina B. Pantcheva, MD; Joel S. Schuman, MD, FACS; Malik Y. Kahook, MD; and David L. Epstein, MD, MMM
Section VI Combined Mechanisms
Chapter 38 Combined Open-Angle and Angle-Closure Glaucoma Joel S. Schuman, MD, FACS and David L. Epstein, MD, MMM
Chapter 39 Glaucoma in the Pseudophakic and Aphakic Eye Ian P. Conner, MD, PhD; Joel S. Schuman, MD, FACS; and David L. Epstein, MD, MMM
Glaucoma Surgery in Pseudophakia and Aphakia: A Historical Perspective: R. Rand Allingham, MD
Chapter 40 Characteristically Unilateral Glaucomas: Differential Diagnosis Joel S. Schuman, MD, FACS; Malik Y. Kahook, MD; and David L. Epstein, MD, MMM
Chapter 41 Glaucoma Secondary to Intraocular Tumors Sumit P. Shah, MD and Jay S. Duker, MD
Section VII Secondary Open-Angle Glaucoma
Chapter 42 Glaucoma Due to Intraocular Inflammation Zvia Burgansky-Eliash, MD; Guy Aharon Weiss, MD; and R. Rand Allingham, MD
Chapter 43 Glaucoma Due to Trauma Carla I. Bourne, MD and Bradford J. Shingleton, MD
Secondary Glaucoma in Black Patients: A Historical Perspective: Morton F. Goldberg, MD
Iris Retraction Syndrome: Joel S. Schuman, MD, FACS
Chapter 44 Corticosteroid Glaucoma Mina B. Pantcheva, MD
Chapter 45 Hemolytic or Ghost-Cell Glaucoma David L. Epstein, MD, MMM
Chapter 46 Glaucoma Associated With Extraocular Venous Congestion (Increased Episcleral Venous Pressure) Ian P. Conner, MD, PhD; Joel S. Schuman, MD, FACS; and David L. Epstein, MD, MMM
Aqueous Humor Dynamics: A Trick Question: David L. Epstein, MD, MMM
Chapter 47 Lens-Induced Glaucoma Ian P. Conner, MD, PhD; Joel S. Schuman, MD, FACS; and David L. Epstein, MD, MMM
Understanding Lens-Induced Glaucomas: Ian P. Conner, MD, PhD and David L. Epstein, MD, MMM
Completely Dislocated Hypermature Cataract and Glaucoma: Ian P. Conner, MD, PhD; Joel S. Schuman, MD, FACS; and David L. Epstein, MD, MMM
Chapter 48 Amyloidosis and Open-Angle Glaucoma David L. Epstein, MD, MMM
Chapter 49 Glaucoma in the Phakomatoses Cynthia Mattox, MD and Priti Batta, MD
Chapter 50 Juvenile Open-Angle Glaucoma Janey L. Wiggs, MD, PhD
Section VIII Laser Methods in Glaucoma
Chapter 51 Glaucoma Laser Surgery Jeremy B. Wingard, MD and Joel S. Schuman, MD, FACS
Chapter 52 Laser Trabeculoplasty Jeremy B. Wingard, MD and Joel S. Schuman, MD, FACS
Chapter 53 Laser Trabeculoplasty: How Does It Work? Daniel Cotlear, MD; Shlomo Melamed, MD; and Modi Goldenfeld, MD
How I Do Laser Trabeculopasty: Claudia U. Richter, MD
Chapter 54 Post-Laser Elevation of Intraocular Pressure Marshall N. Cyrlin, MD
Chapter 55 Laser Peripheral Iridotomy Lisa S. Gamell, MD; Timothy Saunders, MD; and Joel S. Schuman, MD, FACS
The Choice of Iridotomy Lens: Joel S. Schuman, MD, FACS
Technique of Laser Iridotomy: Lisa S. Gamell, MD
Which Laser Should I Use?: Lisa S. Gamell, MD
One Technique for Laser Peripheral Iridotomy: Joel S. Schuman, MD, FACS
Chapter 56 Cyclodestruction Mina B. Pantcheva, MD and Joel S. Schuman, MD, FACS
Chapter 57 Laser Peripheral Iridoplasty Lisa S. Gamell, MD and Cristan M. Arena, MD
Practical Considerations for Argon Laser Peripheral Iridoplasty: Lisa S. Gamell, MD
Personal Technique: Lisa S. Gamell, MD
Section IX Glaucoma Surgery
Chapter 58 What to Say to Glaucoma Patients Prior to Filtration Surgery Mahmoud A. Khaimi, MD
Chapter 59 Filtering Surgery in the Management of Glaucoma Mahmoud A. Khaimi, MD and Marcos Reyes, MD
Antiproliferative Therapy for Filtration Surgery: Mahmoud A. Khaimi, MD; Marcos Reyes, MD; and David A. Lee, MD, MS, MBA, FACS, FARVO
Externalized Releasable Sutures in Filtering Surgery: Murray A. Johnstone, MD and Annisa L. Jamil, MD
How to Handle Mitomycin C: David P. Tingey, BA, MD, FRCSC
Chapter 60 Postoperative Management Following Filtration Surgery Mahmoud A. Khaimi, MD and Marcos Reyes, MD
Performing a Choroidal Tap: R. Rand Allingham, MD
Treatment of Hypotonous Maculopathy: Mahmoud A. Khaimi, MD; Marcos Reyes, MD; and R. Rand Allingham, MD
Chapter 61 The Management of Coexisting Cataract and Glaucoma Carla I. Bourne, MD; Bradford J. Shingleton, MD; and Joel S. Schuman, MD, FACS
Chapter 62 Aqueous Shunting Procedures Sarwat Salim, MD, FACS and Malik Y. Kahook, MD
Chapter 63 Cyclodialysis David L. Epstein, MD, MMM
Mystery Diagnosis: David L. Epstein, MD, MMM
Chapter 64 Surgical Peripheral Iridectomy David L. Epstein, MD, MMM
Chapter 65 Schlemm’s Canal Surgery for Glaucoma Management Steven R. Sarkisian Jr, MD and Marcos Reyes, MD
Chapter 66 Suprachoroidal Approach to Glaucoma Surgery Ramesh S. Ayyala, MD, FRCS(E), FRCOphth(Lon); Farhan A. Irshad, MD; and Iqbal “Ike” K. Ahmed, MD, FRCSC
Chapter 67 Treatment of Occludable Angles and Angle Closure With Cataract Extraction Michael A. Alunni, MD and Garry P. Condon, MD
Section X Diagnosis and Treatment of Glaucoma in Children
Chapter 68 Pediatric Glaucoma Richard W. Hertle, MD, FAAO, FACS, FAAP
Chapter 69 Unusual Pediatric Glaucomas Vicki M. Chen, MD and David S. Walton, MD
Section XI Special Considerations
Chapter 70 The Role of the Cornea in Managing Glaucoma Leon W. Herndon Jr, MD
Chapter 71 Twenty-Four-Hour Intraocular Pressure Monitoring in Glaucoma Brian J. Song, MD and Lama A. Al-Aswad, MD
Chapter 72 The Role of Ocular Perfusion Pressure in the Pathogenesis of Glaucoma Yvonne Ou, MD and Sanjay Asrani, MD
Topical Medications and Ocular Perfusion Pressure: Yvonne Ou, MD and Sanjay Asrani, MD
Chapter 73 Neuroprotection in Glaucoma Yvonne Ou, MD and Stuart J. McKinnon, MD, PhD
Chapter 74 Adherence to Glaucoma Medical Therapy Lisa S. Gamell, MD and Gretta Fridman, MD
What Do We Actually Do to Ensure Adherence?: Lisa S. Gamell, MD
Chapter 75 Epidemiology of Glaucoma Michael B. Horsley, MD and M. Roy Wilson, MD, MS
Financial Disclosures
Index
| Sprache | englisch |
|---|---|
| Maße | 216 x 279 mm |
| Gewicht | 2710 g |
| Themenwelt | Medizin / Pharmazie ► Medizinische Fachgebiete ► Augenheilkunde |
| ISBN-10 | 1-55642-954-1 / 1556429541 |
| ISBN-13 | 978-1-55642-954-5 / 9781556429545 |
| Zustand | Neuware |
| Haben Sie eine Frage zum Produkt? |
aus dem Bereich
